+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

Cell Free DNA (cfDNA) Testing Global Market Report 2024 - Product Thumbnail Image

Cell Free DNA (cfDNA) Testing Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Genotyping Market Report 2025 - Product Thumbnail Image

Genotyping Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neoantigen Targeted Therapies Market Report 2025 - Product Thumbnail Image

Neoantigen Targeted Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
AI in Genomics Market Report 2025 - Product Thumbnail Image

AI in Genomics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Optical Genome Mapping Global Market Report 2024 - Product Thumbnail Image

Optical Genome Mapping Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
Oncolytic Virus Cancer Therapy Market - Product Thumbnail Image

Oncolytic Virus Cancer Therapy Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more